Quick Answer
Whitehawk Therapeutics, Inc. reported Cash And Cash Equivalents At Carrying Value of $37.57 million for the year ending 2025.
- Whitehawk Therapeutics, Inc. showed an increase of +31.0% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Whitehawk Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2007 to 2025 (22 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2007: $0.00 | Q2 2010: $5.8 thousand | Q3 2010: $2.3 thousand | Q1 2011: $24.6 thousand | Q2 2011: $9.2 thousand | Q1 2012: $23.6 thousand | Q2 2012: $9.3 thousand | Q1 2013: $2.7 thousand | Q2 2013: $2.7 thousand | Q3 2013: $10.3 thousand | Q1 2014: $5.9 thousand | Q2 2014: $4.6 thousand | Q3 2014: $17.9 thousand | Q1 2015: $23.3 thousand | Q2 2015: $10.1 thousand | Q1 2016: $1.16 million | Q2 2016: $1.60 million | Q3 2016: $1.31 million | Q1 2017: $35.14 million | Q2 2017: $28.85 million | Q3 2017: $24.83 million | Q4 2017: $20.26 million | Q1 2018: $13.76 million | Q2 2018: $68.78 million | Q3 2018: $68.81 million | Q1 2019: $53.42 million | Q2 2019: $48.16 million | Q3 2019: $43.39 million | Q1 2020: $34.58 million | Q2 2020: $44.86 million | Q3 2020: $47.28 million | Q1 2021: $39.01 million | Q2 2021: $36.82 million | Q3 2021: $161.38 million | Q1 2022: $129.85 million | Q2 2022: $118.74 million | Q3 2022: $134.82 million | Q1 2023: $34.05 million | Q2 2023: $68.16 million | Q3 2023: $68.80 million | Q1 2024: $53.78 million | Q2 2024: $41.14 million | Q3 2024: $30.54 million | Q1 2025: $227.57 million | Q2 2025: $144.94 million | Q3 2025: $37.93 million.
- Historical annual values: Fiscal year 2025: $37.57 million | Fiscal year 2024: $28.67 million | Fiscal year 2023: $62.89 million | Fiscal year 2022: $39.02 million | Fiscal year 2021: $148.99 million | Fiscal year 2020: $4.46 million | Fiscal year 2019: $38.52 million | Fiscal year 2018: $62.61 million | Fiscal year 2017: $20.26 million | Fiscal year 2016: $1.61 million | Fiscal year 2015: $5.14 million | Fiscal year 2015: $6.3 thousand | Fiscal year 2014: $5.3 thousand | Fiscal year 2013: $6.3 thousand | Fiscal year 2012: $4.6 thousand | Fiscal year 2012: $5.4 thousand | Fiscal year 2011: $4.1 thousand | Fiscal year 2011: $6.1 thousand | Fiscal year 2010: $26.9 thousand | Fiscal year 2009: $11.1 thousand | Fiscal year 2007: $0.00 | Fiscal year 2007: $0.00.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: